32P-HPLC analysis of N1-(2-carboxy-2-hydroxyethyl)deoxyadenosine: A DNA adduct of the acrylamide-derived epoxide glycidamide

Toxicology Letters

Volumn 207, Issue 1, 2011, Pages 18-24

  Kotova, Natalia ^a,e   Jurén, Tina ^a   Myöhänen, Kirsi ^b   Cornelius, Michael ^a   Abramsson Zetterberg, Lilianne ^d   Backman, Josefin ^c   Menzel, Ulrike ^a   Rydberg, Per ^e   Kronberg, Leif ^c   Vähäkangas, Kirsi ^b   Segerbäck, Dan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c ÅBO AKADEMI UNIVERSITY   (Finland)

^d NATIONAL FOOD ADMINISTRATION   (Sweden)

^e STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

32P postlabelling; Acrylamide; DNA adducts; Glycidamide

Indexed keywords

ACRYLAMIDE; BIOLOGICAL MARKER; CELL DNA; DEOXYADENOSINE DERIVATIVE; DEOXYADENOSINE DIPHOSPHATE; GLYCIDAMIDE; N1 (2 CARBOXY 2 HYDROXYETHYL)DEOXYADENOSINE; PHOSPHORUS 32; UNCLASSIFIED DRUG; EPOXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DNA ADDUCT; DNA DETERMINATION; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYNTHESIS; TANDEM MASS SPECTROMETRY; ANIMAL; CHO CELL; CRICETULUS; HAMSTER; METABOLISM; METHODOLOGY; MONONUCLEAR CELL; ULTRAVIOLET SPECTROPHOTOMETRY;

MUS;

ACRYLAMIDE; ANIMALS; CHO CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRICETINAE; CRICETULUS; DEOXYADENOSINES; DNA ADDUCTS; EPOXY COMPOUNDS; HUMANS; LEUKOCYTES, MONONUCLEAR; MICE; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 80052842614     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.08.007     Document Type: Article

References (39)

1. Bergmark E. Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers, smokers and nonsmokers. Chem. Res. Toxicol. 1997, 10:78-84.
2. Besaratinia A., Pfeifer G.P. Genotoxicity of acrylamide and glycidamide. J. Natl. Cancer Inst. 2004, 96:1023-1029.
3. Besaratinia A., Pfeifer G.P. A review of mechanisms of acrylamide carcinogenicity. Carcinogenesis 2007, 28:519-528.
4. Calleman C.J., Wu Y., He F., Tian G., Bergmark E., Zhang S., Deng H., Wang Y., Crofton K.M., Fennell T., et al. Relationships between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide. Toxicol. Appl. Pharmacol. 1994, 126:361-371.
5. Carere A. Genotoxicity and carcinogenicity of acrylamide: a critical review. Ann. Ist. Super Sanita 2006, 42:144-155.
6. Czene K., Osterman-Golkar S., Yun X., Li G., Zhao F., Perez H.L., Li M., Natarajan A.T., Segerback D. Analysis of DNA and hemoglobin adducts and sister chromatid exchanges in a human population occupationally exposed to propylene oxide: a pilot study. Cancer Epidemiol. Biomarkers Prev. 2002, 11:315-318.
7. Doerge D.R., Young J.F., Chen J.J., Dinovi M.J., Henry S.H. Using dietary exposure and physiologically based pharmacokinetic/pharmacodynamic modeling in human risk extrapolations for acrylamide toxicity. J. Agric. Food Chem. 2008, 56:6031-6038.
8. Dybing E., Farmer P.B., Andersen M., Fennell T.R., Lalljie S.P., Muller D.J., Olin S., Petersen B.J., Schlatter J., Scholz G., Scimeca J.A., Slimani N., Tornqvist M., Tuijtelaars S., Verger P. Human exposure and internal dose assessments of acrylamide in food. Food Chem. Toxicol. 2005, 43:365-410.
9. Gamboa da Costa G., Churchwell M.I., Hamilton L.P., Von Tungeln L.S., Beland F.A., Marques M.M., Doerge D.R. DNA adduct formation from acrylamide via conversion to glycidamide in adult and neonatal mice. Chem. Res. Toxicol. 2003, 16:1328-1337.
10. Ghanayem B.I., McDaniel L.P., Churchwell M.I., Twaddle N.C., Snyder R., Fennell T.R., Doerge D.R. Role of CYP2E1 in the epoxidation of acrylamide to glycidamide and formation of DNA and hemoglobin adducts. Toxicol. Sci. 2005, 88:311-318.
11. Granath F., Törnqvist M. Who knows whether acrylamide in food is hazardous to humans?. J. Natl. Cancer Inst. 2003, 95:842-843.
12. Hagmar L., Törnqvist M. Inconclusive results from an epidemiological study on dietary acrylamide and cancer. Br. J. Cancer 2003, 89:774-775. (author reply: 775-776).
13. Hagmar L., Törnqvist M., Nordander C., Rosén I., Bruze M., Kautiainen A., Magnusson A.L., Malmberg B., Aprea P., Granath F., Axmon A. Health effects of occupational exposure to acrylamide using hemoglobin adducts as biomarkers of internal dose. Scand. J. Work Environ. Health 2001, 27:219-226.
14. Hogervorst J.G., Baars B.J., Schouten L.J., Konings E.J., Goldbohm R.A., van den Brandt P.A. The carcinogenicity of dietary acrylamide intake: a comparative discussion of epidemiological and experimental animal research. Crit. Rev. Toxicol. 2010, 40:485-512.
15. IARC, 1994. Acrylamide. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Some Industrial Chemicals, vol. 60. International Agency for Research on Cancer, Lyon, pp. 389-433.
16. Klaunig J.E. Acrylamide carcinogenicity. J. Agric. Food Chem. 2008, 56:5984-5988.
17. Koskinen M., Plna K. Specific DNA adducts induced by some mono-substituted epoxides in vitro and in vivo. Chem. Biol. Interact. 2000, 129:209-229.
18. Kutting B., Uter W., Drexler H. The association between self-reported acrylamide intake and hemoglobin adducts as biomarkers of exposure. Cancer Causes Control 2008, 19:273-281.
19. Lagerqvist A., Håkansson D., Prochazka G., Lundin C., Dreij K., Segerbäck D., Jernström B., Törnqvist M., Seidel A., Erixon K., Jenssen D. Both replication bypass fidelity and repair efficiency influence the yield of mutations per target dose in intact mammalian cells induced by benzo[a]pyrene-diol-epoxide and dibenzo[a,l]pyrene-diol-epoxide. DNA Repair (Amst.) 2008, 7:1202-1212.
20. Mottram D.S., Wedzicha B.L., Dodson A.T. Acrylamide is formed in the Maillard reaction. Nature 2002, 419:448-449.
21. Olesen P.T., Olsen A., Frandsen H., Frederiksen K., Overvad K., Tjønneland A. Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish Diet, Cancer and Health Study. Int. J. Cancer 2008, 122:2094-2100.
22. Payne G.B., Williams P.H. Reaction of hydrogen peroxide. J. Org. Chem. 2004, 26:651-659.
23. Pelucchi C., La Vecchia C., Bosetti C., Boyle P., Boffetta P. Exposure to acrylamide and human cancer - a review and meta-analysis of epidemiologic studies. Ann. Oncol. 2011.
24. 6-substituted adenine and 3-substituted cytosine/uracil: formation and persistence in vitro and in vivo. Carcinogenesis 1999, 20:2025-2032.
25. 32P-Postlabelling of DNA adducts formed by allyl glycidyl ether in vitro and in vivo. Carcinogenesis 1997, 18:1457-1462.
26. 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5′-monophosphates. Carcinogenesis 1989, 10:1231-1239.
27. Rice J.M. The carcinogenicity of acrylamide. Mutat. Res. 2005, 580:3-20.
28. Rosén J., Hellenäs K.E. Analysis of acrylamide in cooked foods by liquid chromatography tandem mass spectrometry. Analyst 2002, 127:880-882.
29. 14C]acrylamide. Carcinogenesis 1995, 16:1161-1165.
30. Selzer R.R., Elfarra A.A. In vitro reactions of butadiene monoxide with single- and double-stranded DNA: characterization and quantitation of several purine and pyrimidine adducts. Carcinogenesis 1999, 20:285-292.
31. Stadler R.H., Blank I., Varga N., Robert F., Hau J., Guy P.A., Robert M.C., Riediker S. Acrylamide from Maillard reaction products. Nature 2002, 419:449-450.
32. Svensson K., Abramsson L., Becker W., Glynn A., Hellenäs K.E., Lind Y., Rosén J. Dietary intake of acrylamide in Sweden. Food Chem. Toxicol. 2003, 41:1581-1586.
33. Tareke E., Rydberg P., Karlsson P., Eriksson S., Törnqvist M. Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J. Agric. Food Chem. 2002, 50:4998-5006.
34. Tyl R.W., Friedman M.A. Effects of acrylamide on rodent reproductive performance. Reprod. Toxicol. 2003, 17:1-13.
35. Urban M., Kavvadias D., Riedel K., Scherer G., Tricker A.R. Urinary mercapturic acids and a hemoglobin adduct for the dosimetry of acrylamide exposure in smokers and nonsmokers. Inhal. Toxicol. 2006, 18:831-839.
36. Vesper H.W., Bernert J.T., Ospina M., Meyers T., Ingham L., Smith A., Myers G.L. Assessment of the relation between biomarkers for smoking and biomarkers for acrylamide exposure in humans. Cancer Epidemiol. Biomarkers Prev. 2007, 16:2471-2478.
37. Von Tungeln L.S., Churchwell M.I., Doerge D.R., Shaddock J.G., McGarrity L.J., Heflich R.H., da Costa G.G., Marques M.M., Beland F.A. DNA adduct formation and induction of micronuclei and mutations in B6C3F1/Tk mice treated neonatally with acrylamide or glycidamide. Int. J. Cancer 2009, 124:2006-2015.
38. WHO, 2007. http://www.who.int/foodsafety/chem/chemicals/acrylamide/en/index.html.
39. Wirfält E., Paulsson B., Törnqvist M., Axmon A., Hagmar L. Associations between estimated acrylamide intakes, and hemoglobin AA adducts in a sample from the Malmo Diet and Cancer cohort. Eur. J. Clin. Nutr. 2008, 62:314-323.